The conclusion is that the type 1 diabetic patients that presented lower BMI and lower insulin dose in the pretransplant period were the ones that developed hyperglycemia less frequently, i.e., approximately in 11% [44]. This evidence concerns the gene INS and type 1 diabetes mellitus.